Vatche Bartekian, President & Founder of Vantage BioTrials, Listed As One of Emerging Pharma Leaders of 2011

June 15, 2011, Montreal, Canada – It is with pleasure to announce that Pharm Exec, one of the most reputable and trusted Pharma Magazines in the world, published on June 1, 2011 an article entitled “Meet 2011’s Emerging Pharma Leaders—Can these 30 trendsetters build competitive scale from scarcity?”.

It is with even greater pleasure that Vantage BioTrials’ President & Founder, Vatche Bartekian, has been chosen
amongst the 30 highly profiled individuals as one of the Emerging Pharma Leaders in 2011.

As a company, and on a personal level, we are elated and take pride in this achievement.

To read more about this article, please click on the following URL which will direct you to Pham Exec’s article:

http://pharmexec.findpharma.com/pharmexec/article/articleDetail.jsp?id=726109&sk=&date=&pageID
=6

About Vantage BioTrials Inc.

Vantage BioTrials Inc. is a privately owned Clinical Trial Management Organization (CTMO) based in Montréal Canada that provides superior trial management services and combines a precise blend of clinical development knowledge, talent and resources that will ensure a clinical study’s full potential. By servicing our global Pharmaceutical, Biotech and Generic clients who perform Phase I, II-IV clinical trials, our goal is to exceed their expectations by offering outstanding monitoring, project management and clinical operation services.

Tags:
Categorynews-pressroom